New study finds GLP-1 agonists and SGLT2 inhibitors associated with reduced risk of dementia in type 2 diabetes patients compared to other glucose-lowering medications.
A novel CSF protein ratio, YWHAG:NPTX2, outperforms traditional biomarkers in predicting cognitive resilience vs progressive cognitive impairment in patients with Alzheimer's disease.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.